PriceTargets.com logo

Uniphar - UPR Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 360 As of 09/9/2026 11:11 AM ET
+0 (0.00%)

This chart shows the closing price for UPR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Uniphar Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UPR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UPR

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Uniphar in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 360.

This chart shows the closing price for UPR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Uniphar. This rating has held steady since July 2026, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/18/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/16/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/14/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/13/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/13/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/11/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/10/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/9/2026

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/9/2025Royal Bank Of CanadaBoost TargetOutperformGBX 470 ➝ GBX 480
7/30/2025Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 375
5/29/2025Shore Capital GroupReiterated RatingBuy
2/25/2025Shore Capital GroupReiterated RatingBuy
1/28/2025Shore Capital GroupReiterated RatingBuy
9/4/2024Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 310
3/22/2023Shore Capital GroupReiterated RatingBuy
(Data available from 9/9/2021 forward)

News Sentiment Rating

-0.36 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/11/2026
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/13/2026
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/12/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/12/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/11/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/11/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/10/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/9/2026

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
Uniphar logo
Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.
Read More

Today's Range

Now: GBX 360
Low: 350
High: 370

50 Day Range

MA: GBX 373.30
Low: 353
High: 404

52 Week Range

Now: GBX 360
Low: 294
High: 428

Volume

21,653 shs

Average Volume

91,124 shs

Market Capitalization

£934.47 million

P/E Ratio

18.46

Dividend Yield

0.50%

Beta

1.102

Frequently Asked Questions

What sell-side analysts currently cover shares of Uniphar?

The following Wall Street analysts have issued research reports on Uniphar in the last twelve months: Royal Bank Of Canada.
View the latest analyst ratings for UPR.

What is the current price target for Uniphar?

0 Wall Street analysts have set twelve-month price targets for Uniphar in the last year. has the lowest price target set, forecasting a price of £100,000 for Uniphar in the next year.
View the latest price targets for UPR.

What is the current consensus analyst rating for Uniphar?

Uniphar currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for UPR.

What other companies compete with Uniphar?

Other companies that are similar to Uniphar include UDG Healthcare, Spire Healthcare Group, Medica Group, Sourcebio International and One Health Group. Learn More about companies similar to Uniphar.

How do I contact Uniphar's investor relations team?

Uniphar's physical mailing address is 4045 Kingswood Road, Citywest Business Park, Dublin D24 V06K, Ireland. The company's listed phone number is 353 1 428 7777. The official website for Uniphar is www.uniphar.ie. Learn More about contacing Uniphar investor relations.